7月28日，麦克森药物批发盘中上涨3.05%，报878.34美元/股，成交额1.3亿美元。
消息面上，公司近日宣布将季度股息由每股0.82美元上调15%至0.94美元，实现连续第10年股息增长，将于10月1日支付给9月1日登记在册的股东。与此同时，多家机构近期密集上调目标价：花旗集团将目标价从945美元上调至1,000美元维持买入；Baird上调至955美元维持跑赢大盘；美国银行上调至925美元。当前FactSet汇总均价目标约947.73美元，市场共识评级为买入。此外，公司下一份财报将于8月5日盘后发布，市场预期调整后EPS为9.59美元。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.